Improving the Treatment Effect of Carotenoids on Alzheimer’s Disease through Various Nano-Delivery Systems

Natural bioactive compounds have recently emerged as a current strategy for Alzheimer’s disease treatment. Carotenoids, including astaxanthin, lycopene, lutein, fucoxanthin, crocin and others are natural pigments and antioxidants, and can be used to treat a variety of diseases, including Alzheimer’s...

Full description

Bibliographic Details
Main Authors: Wenjing Su, Wenhao Xu, Enshuo Liu, Weike Su, Nikolay E. Polyakov
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/8/7652
_version_ 1797605033140813824
author Wenjing Su
Wenhao Xu
Enshuo Liu
Weike Su
Nikolay E. Polyakov
author_facet Wenjing Su
Wenhao Xu
Enshuo Liu
Weike Su
Nikolay E. Polyakov
author_sort Wenjing Su
collection DOAJ
description Natural bioactive compounds have recently emerged as a current strategy for Alzheimer’s disease treatment. Carotenoids, including astaxanthin, lycopene, lutein, fucoxanthin, crocin and others are natural pigments and antioxidants, and can be used to treat a variety of diseases, including Alzheimer’s disease. However, carotenoids, as oil-soluble substances with additional unsaturated groups, suffer from low solubility, poor stability and poor bioavailability. Therefore, the preparation of various nano-drug delivery systems from carotenoids is a current measure to achieve efficient application of carotenoids. Different carotenoid delivery systems can improve the solubility, stability, permeability and bioavailability of carotenoids to a certain extent to achieve Alzheimer’s disease efficacy. This review summarizes recent data on different carotenoid nano-drug delivery systems for the treatment of Alzheimer’s disease, including polymer, lipid, inorganic and hybrid nano-drug delivery systems. These drug delivery systems have been shown to have a beneficial therapeutic effect on Alzheimer’s disease to a certain extent.
first_indexed 2024-03-11T04:55:23Z
format Article
id doaj.art-adb3d4b8c0cf4e7188fde553e83e2edf
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T04:55:23Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-adb3d4b8c0cf4e7188fde553e83e2edf2023-11-17T19:43:41ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-04-01248765210.3390/ijms24087652Improving the Treatment Effect of Carotenoids on Alzheimer’s Disease through Various Nano-Delivery SystemsWenjing Su0Wenhao Xu1Enshuo Liu2Weike Su3Nikolay E. Polyakov4Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, ChinaCollaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, ChinaCollaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, ChinaCollaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, ChinaInstitute of Solid State Chemistry and Mechanochemistry, 630128 Novosibirsk, RussiaNatural bioactive compounds have recently emerged as a current strategy for Alzheimer’s disease treatment. Carotenoids, including astaxanthin, lycopene, lutein, fucoxanthin, crocin and others are natural pigments and antioxidants, and can be used to treat a variety of diseases, including Alzheimer’s disease. However, carotenoids, as oil-soluble substances with additional unsaturated groups, suffer from low solubility, poor stability and poor bioavailability. Therefore, the preparation of various nano-drug delivery systems from carotenoids is a current measure to achieve efficient application of carotenoids. Different carotenoid delivery systems can improve the solubility, stability, permeability and bioavailability of carotenoids to a certain extent to achieve Alzheimer’s disease efficacy. This review summarizes recent data on different carotenoid nano-drug delivery systems for the treatment of Alzheimer’s disease, including polymer, lipid, inorganic and hybrid nano-drug delivery systems. These drug delivery systems have been shown to have a beneficial therapeutic effect on Alzheimer’s disease to a certain extent.https://www.mdpi.com/1422-0067/24/8/7652carotenoidsAlzheimer’s diseasenanosized drug delivery systems
spellingShingle Wenjing Su
Wenhao Xu
Enshuo Liu
Weike Su
Nikolay E. Polyakov
Improving the Treatment Effect of Carotenoids on Alzheimer’s Disease through Various Nano-Delivery Systems
International Journal of Molecular Sciences
carotenoids
Alzheimer’s disease
nanosized drug delivery systems
title Improving the Treatment Effect of Carotenoids on Alzheimer’s Disease through Various Nano-Delivery Systems
title_full Improving the Treatment Effect of Carotenoids on Alzheimer’s Disease through Various Nano-Delivery Systems
title_fullStr Improving the Treatment Effect of Carotenoids on Alzheimer’s Disease through Various Nano-Delivery Systems
title_full_unstemmed Improving the Treatment Effect of Carotenoids on Alzheimer’s Disease through Various Nano-Delivery Systems
title_short Improving the Treatment Effect of Carotenoids on Alzheimer’s Disease through Various Nano-Delivery Systems
title_sort improving the treatment effect of carotenoids on alzheimer s disease through various nano delivery systems
topic carotenoids
Alzheimer’s disease
nanosized drug delivery systems
url https://www.mdpi.com/1422-0067/24/8/7652
work_keys_str_mv AT wenjingsu improvingthetreatmenteffectofcarotenoidsonalzheimersdiseasethroughvariousnanodeliverysystems
AT wenhaoxu improvingthetreatmenteffectofcarotenoidsonalzheimersdiseasethroughvariousnanodeliverysystems
AT enshuoliu improvingthetreatmenteffectofcarotenoidsonalzheimersdiseasethroughvariousnanodeliverysystems
AT weikesu improvingthetreatmenteffectofcarotenoidsonalzheimersdiseasethroughvariousnanodeliverysystems
AT nikolayepolyakov improvingthetreatmenteffectofcarotenoidsonalzheimersdiseasethroughvariousnanodeliverysystems